The ansamycins: hypolipidemic agents stimulating cholesterol removal by nonclassical mechanisms. by J C Gibson, W H Lee, J R Piccolo

Get full text

Independent regulation of plasma apolipoprotein C-II and C-III concentrations in very low density and high density lipoproteins: implications for the regulation of the catabolism o... by N A Le, J C Gibson, H N Ginsberg

Get full text

Apolipoprotein E-enriched lipoprotein subclasses in normolipidemic subjects. by J C Gibson, A Rubinstein, P R Bukberg, W V Brown

Get full text

Evidence for non-equilibrating pools of apolipoprotein C-III in plasma lipoproteins. by P R Bukberg, N A Le, H N Ginsberg, J C Gibson, A Rubinstein, W V Brown

Get full text

Direct measurement of apoprotein C-III specific activity in 125I-labeled very low density lipoproteins using immunoaffinity chromatography. by P R Bukberg, N A Le, H N Ginsberg, J C Gibson, L C Goldman, W V Brown

Get full text

Future directions for monitoring and human health research for the Arctic Monitoring and Assessment Programme by B. Adlard, S. G. Donaldson, J.O. Odland, P. Weihe, J. Berner, A. Carlsen, E. C. Bonefeld-Jorgensen, A. A. Dudarev, J.C. Gibson, E.M. Krümmel, K. Olafsdottir, K. Abass, A. Rautio, I.A. Bergdahl, G. Mulvad

Get full text